| # | Drug | Count |
|---|---|---|
| 0 | BENDAMUSTINE HCL | 5 |
| 1 | CYCLOPHOSPHAMIDE | 5 |
| 2 | CYCLOPHOSPHAMIDE FOR INJECTION | 5 |
| 3 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 5 |
| 4 | CYTARABINE | 5 |
| 5 | METHOTREXATE SODIUM | 5 |
| 6 | RITUXIMAB | 5 |
| 7 | MELPHALAN | 4 |
| 8 | MELPHALAN HYDROCHLORIDE | 4 |
| 9 | METHOTREXATE | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | QUIZARTINIB | 1 | 0.0014 |
| 1 | IDARUBICIN HYDROCHLORIDE | 1 | 0.0009 |
| 2 | CARMUSTINE | 3 | 0.0006 |
| 3 | POLATUZUMAB VEDOTIN | 4 | 0.0004 |
| 4 | BENDAMUSTINE HCL | 5 | 0.0003 |
| 5 | GILTERITINIB | 1 | 0.0002 |
| 6 | VANCOMYCIN HYDROCHLORIDE | 2 | 0.0002 |
| 7 | MELPHALAN HYDROCHLORIDE | 4 | 0.0002 |
| 8 | BUSULFAN | 2 | 0.0001 |
| 9 | BRENTUXIMAB VEDOTIN | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD30-directed Immunoconjugate [EPC] | 1 | 0.0001 |
| 1 | Topoisomerase Inhibitor [EPC] | 3 | 0.0000 |
| 2 | Glycopeptide Antibacterial [EPC] | 2 | 0.0000 |
| 3 | Alkylating Drug [EPC] | 5 | 0.0000 |
| 4 | Nucleoside Metabolic Inhibitor [EPC] | 5 | 0.0000 |
| 5 | Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 2 | 0.0000 |
| 6 | Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 2 | 0.0000 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 5 | 0.0000 |
| 8 | Janus Kinase Inhibitor [EPC] | 2 | 0.0000 |
| 9 | Platinum-based Drug [EPC] | 3 | 0.0000 |